Pharmesis International Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmesis International Ltd with three other
pharmaceutical manufacturers in Asia:
N0 25 Central Pharmaceutical JSC
sales of 116.52 billion Vietnamese Dong [US$5.02 million]
Wyeth Pakistan Limited
(948.24 million Pakistan Rupees [US$5.70 million]
Bafna Pharmaceuticals Limited
based in INDIA
(433.59 million Indian Rupees [US$5.90 million]
During the year ended December of 2019, sales at
Pharmesis International Ltd were 7.35 million Singapore Dollars (US$5.41 million).
decrease of 43.9%
versus 2018, when the company's sales were 13.11 million Singapore Dollars.